tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
BridgeBio price target raised to $81 from $73 at Oppenheimer
PremiumThe FlyBridgeBio price target raised to $81 from $73 at Oppenheimer
9d ago
BridgeBio price target raised to $98 from $93 at Piper Sandler
Premium
The Fly
BridgeBio price target raised to $98 from $93 at Piper Sandler
9d ago
BridgeBio Pharma Reports Strong Q3 2025 Results
Premium
Company Announcements
BridgeBio Pharma Reports Strong Q3 2025 Results
9d ago
Optimistic Buy Rating for BridgeBio Pharma: Promising Phase 3 Trial Results and Future Developments
PremiumRatingsOptimistic Buy Rating for BridgeBio Pharma: Promising Phase 3 Trial Results and Future Developments
11d ago
BridgeBio price target raised to $76 from $58 at BofA
Premium
The Fly
BridgeBio price target raised to $76 from $58 at BofA
11d ago
BridgeBio price target raised to $80 from $70 at H.C. Wainwright
Premium
The Fly
BridgeBio price target raised to $80 from $70 at H.C. Wainwright
11d ago
Midday Fly By: Novartis to buy Avidity, Keurig Dr Pepper beats expectations
PremiumThe FlyMidday Fly By: Novartis to buy Avidity, Keurig Dr Pepper beats expectations
12d ago
BridgeBio reports results from FORTIFY Phase 3 study of BBP-418
Premium
The Fly
BridgeBio reports results from FORTIFY Phase 3 study of BBP-418
12d ago
BridgeBio management to meet with Piper Sandler
Premium
The Fly
BridgeBio management to meet with Piper Sandler
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100